Stay up to date

The conference theme, 'Ending the Emergency: Science, Leadership, Action', focused on what is needed to ensure commitments become action, and that lifesaving targets are met.

Congratulations to our EDCTP Fellows who's excellent research work was recognised!

Two Career Development Fellows received prestigious awards:

Dr Stephanus Malherbe received The Union Young Investigator Prize

Dr Sean Wasserman received the Stephen Lawn TB-HIV Research Leadership Prize

https://hyderabad.worldlunghealth.org/2019/11/the-union-recognises-major-contributions-to-lung-health-through-its-annual-awards/

Dr Stellah Mpagama, an EDCTP Senior Fellow gave her plenary presentation during the Ending the TB Emergency session. 

https://www.youtube.com/watch?v=Bw2eCplJ7Y8

Programme submissions for the 23rd International AIDS Conference (AIDS 2020) are now open, including abstracts, the Global Village and Youth Programme, pre-conferences and more.

Present your research
Showcase your work to 20,000 global leaders, scientists, policy makers, healthcare professionals and people living with HIV. Abstract submissions close 14 January 2020.

Join the Global Village and Youth Programme

The Global Village and Youth Programme is an open-access, free and vibrant space where communities from all over the world meet, share and learn from each other. Apply before 14 January 2020.

Organize a workshop
The Workshop Programme offers opportunities for knowledge transfer, skills development and collaborative learning. Workshop proposal submissions close 14 January 2020.

Host an official pre-conference
Pre-conferences are one to two day meetings held immediately before the conference that engage delegates on global health topics. The submission deadline is 14 January 2020.

Apply for a scholarship
The Scholarship Programme supports access to AIDS 2020 for people from resource-limited settings, researchers, young people, key and vulnerable populations, and community representatives. Apply by 15 January 2020.
 

Visit: https://www.aids2020.org/

The Marie Sklodowska-Curie Actions (MSCA) is a European programme which supports researchers' career development, through international and inter-sectorial mobility, as well as innovative training both at PhD and postdoc level. It also funds doctoral programmes. EDCTP was invited to take part in a seminar with 150 participants held 6-7 November 2019 in Addis Ababa, Ethiopia. 

Shingai Machingaidze (EDCTP Project Officer) participated in a panel discussion titled 'Bridging MSCA with existing networks and on-going initiatives'. EDCTP was also represented by 8 EDCTP Fellows as well as 4 junior researchers from the EDCTP Regional Networks of Excellence.

President Museveni has congratulated Dr. Misaki Wayengera, a Researcher at Makerere University College of Health Sciences, for his efforts in developing a rapid test kit to diagnose the deadly Ebola and Marburg viruses. Dr Wayengera is an EDCTP Career Development Fellow (TMA2016CDF1545).

“I want to congratulate our scientists because they are really waking up and producing a lot of products. The Government will fund you. It is the issue of prioritization and putting the money in the right place,” he said. The President was on Tuesday speaking during a meeting at State House, Entebbe to recognize Dr. Misaki Wayengera who recently won the World Health Organization (WHO) high innovation challenge in Product Development Category that took place at the WHO Africa Regional Headquarters in Congo (Brazzaville).

Dr Wayengera’s invention also known as Pan-Filovirus Rapid Diagnostic Test, uses a paper-strip test, like the one used in testing for pregnancy. This, however, will be used in detecting Ebola, Marburg and other hemorrhagic fevers. Africa has had several hemorrhagic fever outbreaks especially Ebola Virus Disease (EVD) with the latest and ongoing outbreak currently in the Democratic Republic of Congo that borders Uganda to the West. Rapid diagnosis is important in informing key decisions especially interventions and measures to take in the event of a disease outbreak. If approved by health authorities including the World Health Organization (WHO) and partners, Dr Wayengera’s Pan-Filovirus Rapid Diagnostic Test will go a long way in improving rapid tests and turnaround time for results during disease outbreaks. President Museveni said that the Government of Uganda will support the efforts of the researchers by establishing a manufacturing facility that will enable them to put all the products together. He commended Dr. Wayengera and his team on the achievements realized adding that the research can bring in a host of benefits to society because the products form the core that addresses many human challenges such as hemorrhage fevers and HIV afflictions that immensely affect the world. The President observed that Uganda has, on several occasions, been attacked by epidemics, including Ebola and Marburg, resulting in the deaths of trained preventive workers and wananchi. State Minister for Health, Hon. Sarah Ochieng Opendi, saluted Dr. Wayengera and his team for the innovation saying their efforts will go a long way in easing the diagnosis of viral hemorrhage fevers such as Ebola and Marburg. Dr. Wayengera, on his part, thanked President Museveni for recognizing their efforts and his support.